Next Article in Journal
EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer
Previous Article in Journal
Bevacizumab Treatment for Patients with NF2-Related Schwannomatosis: A Single Center Experience
 
 
Article

Article Versions Notes

Cancers 2024, 16(8), 1480; https://doi.org/10.3390/cancers16081480
Action Date Notes Link
article xml file uploaded 12 April 2024 13:47 CEST Original file -
article xml uploaded. 12 April 2024 13:47 CEST Update https://www.mdpi.com/2072-6694/16/8/1480/xml
article pdf uploaded. 12 April 2024 13:47 CEST Version of Record https://www.mdpi.com/2072-6694/16/8/1480/pdf
article supplementary file uploaded. 12 April 2024 13:47 CEST - https://www.mdpi.com/2072-6694/16/8/1480#supplementary
article html file updated 12 April 2024 13:49 CEST Original file https://www.mdpi.com/2072-6694/16/8/1480/html
Back to TopTop